GTHX

G1 Therapeutics, Inc. Common Stock

Delisted

GTHX was delisted on the 17th of September, 2024.

88 hedge funds and large institutions have $45.5M invested in G1 Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
+2
Holders Change %
+2.33%
% of All Funds
1.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
26
Increased
33
Reduced
17
Closed
24
Calls
$8.85M
Puts
$6.18M
Net Calls
+$2.68M
Net Calls Change
+$210K
Name Holding Trade Value Shares
Change
Shares
Change %
YIH
101
Y-Intercept (HK)
Hong Kong
-$115K -26,703 Closed
SSA
102
Schonfeld Strategic Advisors
New York
-$86.6K -20,042 Closed
JFG
103
Jefferies Financial Group
New York
-$69.6K -16,100 Closed
Balyasny Asset Management
104
Balyasny Asset Management
Illinois
-$67.5K -15,614 Closed
PAS
105
Point72 Asia (Singapore)
Singapore
-$64.8K -14,991 Closed
OAM
106
Oxford Asset Management
United Kingdom
-$63.5K -14,703 Closed
FAIM
107
Financial Advocates Investment Management
Washington
-$62.4K -14,450 Closed
LP
108
LMR Partners
United Kingdom
-$61.4K -14,216 Closed
CAS
109
CTC Alternative Strategies
Illinois
-$51.8K -12,000 Closed
QT
110
Quantbot Technologies
New York
-$38K -8,800 Closed
Macquarie Group
111
Macquarie Group
Australia
-$6 -1,338 Closed
Lazard Asset Management
112
Lazard Asset Management
New York
-$1K -298 Closed